Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Walking under the microscope: Botox's hidden effects on movement revealed

NCT ID NCT03938363

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how cervical dystonia (neck muscle spasms) and blepharospasm (eye muscle spasms) affect walking. Researchers measured gait in 40 participants before and after botulinum toxin treatment to see if it improves walking patterns. The goal was to better understand these conditions and the treatment's impact on mobility.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Oct 2019

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * speaking French, in the ability to understand clinical tests and explorations, * in ability to move to the CHU Grenoble Alpes * Diagnosis of cervical dystonia or isolated Blepharospasm, * Absence of neurological or psychiatric disorders, * Affiliation to a health insurance, * Signed consent fo the subject. Exclusion Criteria: * Pregnant women (positive pregnancy test), parturient or breastfeeding * Cervical dystonia or Blepharospasm of secondary origin * subjects having benefited from deep brain stimulation, * History of other pathologies that may lead to walking disorders, inability to walk without technical assistance, inability to walk for more than 10 minutes, * Subjects receiving botulinum toxin treatment for another cause. Prohibited treatments and procedures: * Antecedent of pathologies that may cause walking disorders * Simultaneous participation in another Interventional study * Subject in time of exclusion from another study * Subject under guardianship or having curators (major protected) * Subject under administrative or judicial supervision * Subject not able to be contacted in case of emergency

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blepharospasm are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Grenoble Alpes

    La Tronche, Isere, 38700, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.